Organizing committee invites all participants from all over the world to attend “37th International Conference on Psychiatry & Psychosomatic Medicine’’ during June 17-18, 2020 in London, UK.

Psychiatry & Psychosomatic Medicine is a global overview with the Theme: “Application of Psychosomatic Medicine to achieve Mental & Physical Wellness” is designed for professionals at all levels and career phases of Psychiatry, Psychology and neuroscience, who want to improve their understanding of what will drive and shape the future of the market. This will include senior executives, sales and marketing personnel, strategic planners, who will be benefit from a broad overview of psychiatry, psychology and neuroscience. The strength of the Conference is that the participants tend to include all phases of the value chain as well as individuals from a wide variety of sector and countries.

Why to attend???

•  Build your professional network.
•  Hear about the latest research.
•  Improve your presentation and communication skills.
•  Get response on an early version of your latest work.
•  Acquire beyond your field or interest.
•  Get opportunity to people to meet you.
•  Know the strengths and weakness of your conferences.
•  Easier to solve the problems and struggles which you go through at work.

Target Audience:

• Scientists
• Young  research  fellows
• Research Scholars
• Residents, Fellows & Post Docs
• Students
• Medical, Pharmaceutical, Technology Companies
• Business Executives & Directors
• Psychiatry Associations
• Advertising Agency Executives
• Industry professionals

Market Growth of Psychiatry:

Psychiatry is more vital to the common public than ever before, and with the rise of reported mental health and behavior health issues, it might seem a bit confusing as to why personalities still tend to ignore the consequences of leaving these symptoms crude. The Center for Disease Control and Prevention (CDC) has reported that the suicide rate of Americans aged 35-64 years has risen almost 29 percent from 1999 to 2010.  In Europe, the rate of employees reporting mental health issues to their employers has risen to two out of every five workers. Tremendous amounts of studies, an increase in global awareness and a shift in attitude towards treating and helping those with behavioral or mental health issues has likely brought more of these issues to light.

About 14% of the global burden of disease has been attributed to neuropsychiatric disorders, as by 2020, it is estimated to be that the burden of a mental disorder will have to be increased to 15 % of the Disability Adjusted Life Years, which is termed to be (DALYs). Mostly due to the regularly disabling nature of depression and other common mental disorders, alcohol-use and psychosis. Such estimates have drawn helpfulness to the importance of mental disorders for public health. The problem of mental disorders is likely to have been misjudged because of inadequate appreciation of the connectedness between psychological illness and other health disorders.

The global psychiatrists market reached a value of nearly $197.0 billion in 2019, having grown at a compound annual growth rate (CAGR) of 6.0% since 2015, and is expected to grow at a CAGR of 6.9% to reach nearly $256.9 billion by 2023.

Best Regards

Adriana Morris | Program Director        
Psychosomatic Medicine 2020

+44 8000148923
psychosomaticmedicine@brainstormingmeetings.com  
https://psychosomatic.conferenceseries.com/